Keywords
CRISPR
iPSCs
How to Cite
Abstract
Cystic fibrosis is a genetic disease that affects people all over the word. It is caused by specific mutations in the gene responsible for coding the CFTR protein, the cystic fibrosis transmembrane conductance regulator. This article aims to give an update regarding gene therapy using gene editing tools i.e. CRISPR-Cas9.
This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. The authors keep the copyright and publication rights in the journal the right of the first publication and this possibility to edit, reproduce, distribute, expose and publicly communicate on the magazine's website. Likewise, it assumes the commitment on any litigation or claim related to the rights of intellectual property, exonerating of responsibility to the Science and Health Magazine of the UCIMED. In addition, you can see how they are published in this journal (eg, Include in an institutional repository or publish it in a book) as long as they clearly indicate the work published for the first time in the magazine Science and Health of the UCIMED.